Study to assess prevalence of BRCA1 and BRCA2 mutation among ovarian, primary peritoneal and fallopian tube cancer patients in India

Trial Identifier: D0818R00001
Sponsor: AstraZeneca
NCTID:: NCT03471572
Start Date: March 2018
Primary Completion Date: December 2018
Study Completion Date: December 2018
Condition: Ovarian Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India, Karnataka Bangalore, Karnataka, India, 560027
India, Maharashtra Mumbai, Maharashtra, India, 400071
India, Maharashtra Mumbai, Maharashtra, India, 400012
India, New Delhi Delhi, New Delhi, India, 110060
India, New Delhi Delhi, New Delhi, India, 110017
India, New Delhi Delhi, New Delhi, India, 110005
India, Telangana Hyderabad, Telangana, India, 500034
India, West Bengal Kolkata, West Bengal, India, 700099